Mm1 (E887abe7 4443 4b77 8e84 4c7cc0098e94 01)
Ondansetron Tablet, Orally Disintegrating
Product Images NDC 83980-012
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 83980-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ipca Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mm3 (E887abe7 4443 4b77 8e84 4c7cc0098e94 02)
This is the description of Ondansetron Orally Disintegrating Tablets, USP. It contains phenylalanine and should be stored at 20°C to 25°C (68°F to 77°F). The usual dosage should be followed as per the package insert for proper administration. These tablets are made in India and distributed by Unichem Pharmaceuticals.*
Mm6 (E887abe7 4443 4b77 8e84 4c7cc0098e94 03)
This is a description of Ondansetron orally disintegrating tablets, each containing 8mg. These tablets are suitable for phenylketonurics and should be stored at temperatures between 20°C to 25°C. The packaging includes 30 tablets and the product is distributed by Unichem Pharmaceuticals USA, Inc. The recommended dosage should be administered using acid-resistant dosing, and the tablets must be taken straight from the bottle immediately before use. Made in India, the tablets are for controlled room temperature use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
